Paper39239276
The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation.
Vanthienen W and 16 others. Front Oncol, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation. Papers, record 39239276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39239276
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37726064 | The Warburg effect on radioresistance: Survival beyond growth. | Biochim Biophys Acta Rev Cancer | 2023 | https://conductscience.org/library/papers/37726064 | PubMed |
| 2 | 5721900 | Transport-associated phosphorylation of 2-deoxy-D-glucose in yeast. | Biochim Biophys Acta | 1968 | https://conductscience.org/library/papers/5721900 | PubMed |
| 3 | 22382780 | 3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue. | J Bioenerg Biomembr | 2012 | https://conductscience.org/library/papers/22382780 | PubMed |
| 4 | 30464533 | Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30464533 | PubMed |
| 5 | 33109759 | Aberrant Intracellular pH Regulation Limiting Glyceraldehyde-3-Phosphate Dehydrogenase Activity in the Glucose-Sensitive Yeast tps1Δ Mutant. | mBio | 2020 | https://conductscience.org/library/papers/33109759 | PubMed |
| 6 | 37069111 | Warburg Effect Revisited: Embodiment of Classical Biochemistry and Organic Chemistry. Current State and Prospects. | Biochemistry (Mosc) | 2023 | https://conductscience.org/library/papers/37069111 | PubMed |
| 7 | 1514678 | A method for the determination of changes of glycolytic metabolites in yeast on a subsecond time scale using extraction at neutral pH. | Anal Biochem | 1992 | https://conductscience.org/library/papers/1514678 | PubMed |
| 8 | 9618445 | Yeast carbon catabolite repression. | Microbiol Mol Biol Rev | 1998 | https://conductscience.org/library/papers/9618445 | PubMed |
| 9 | 2372287 | Over-expression of facilitative glucose transporter genes in human cancer. | Biochem Biophys Res Commun | 1990 | https://conductscience.org/library/papers/2372287 | PubMed |
| 10 | 8279829 | Kinetics of growth and sugar consumption in yeasts. | Antonie Van Leeuwenhoek | 1993 | https://conductscience.org/library/papers/8279829 | PubMed |
| 11 | 35628385 | Targeting Energy Metabolism in Cancer Treatment. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628385 | PubMed |
| 12 | 9299703 | The molecular genetics of hexose transport in yeasts. | FEMS Microbiol Rev | 1997 | https://conductscience.org/library/papers/9299703 | PubMed |
| 13 | 16640561 | Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase. | FEBS J | 2006 | https://conductscience.org/library/papers/16640561 | PubMed |
| 14 | 28492237 | Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. | Nat Commun | 2017 | https://conductscience.org/library/papers/28492237 | PubMed |
| 15 | 22328057 | Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug. | J Bioenerg Biomembr | 2012 | https://conductscience.org/library/papers/22328057 | PubMed |
| 16 | 25277420 | The Warburg effect: evolving interpretations of an established concept. | Free Radic Biol Med | 2015 | https://conductscience.org/library/papers/25277420 | PubMed |
| 17 | 2645056 | Elevated recombination rates in transcriptionally active DNA. | Cell | 1989 | https://conductscience.org/library/papers/2645056 | PubMed |
| 18 | 29960885 | Four Key Steps Control Glycolytic Flux in Mammalian Cells. | Cell Syst | 2018 | https://conductscience.org/library/papers/29960885 | PubMed |
| 19 | 28042452 | Anticancer agents interacting with membrane glucose transporters. | Medchemcomm | 2016 | https://conductscience.org/library/papers/28042452 | PubMed |
| 20 | 20678861 | Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms. | Cancer Lett | 2010 | https://conductscience.org/library/papers/20678861 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42323674 | Multilayered control of hexose uptake and phosphorylation through specialized sugar kinases in Nakaseomyces glabratus. | Fungal Biol Biotechnol | 2026 | https://conductscience.org/library/papers/42323674 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39239276
GET https://conductscience.org/api/papers/v1/39239276/references?page=2